Back to search

Article

To cure or not to cure: consequences of immunological interactions in CML treatment

2018-12-13

Abstract excerpt

Recent clinical findings in Chronic Myeloid Leukemia (CML) patients suggest that the number and function of immune effector cells are modulated by Tyrosine Kinase Inhibitors (TKI) treatment. There is further evidence that the success or failure of treatment cessation at least partly depends on the patient’s immunological constitution. Here, we propose a general ODE model to functionally describe the interactions b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e1afa32f-7051-598a-8fb3-a68fa3819037
DOI
10.1101/494575
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
To cure or not to cure: consequences of immunological interactions in CML treatmentDOI 10.1101/494575
Predicting treatment-free remission outcomes in Chronic Myeloid Leukemia patients using an integrated model of tumor-immune dynamicsSemantic proximity
Early Dynamics of Chronic Myeloid Leukemia on Nilotinib Predicts Deep Molecular ResponseSemantic proximity
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapySemantic proximity
Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasmsSemantic proximity
Differential response to cytotoxic therapy explains treatment dynamics of acute myeloid leukaemia patients: insights from a mathematical modelling approachSemantic proximity
Understanding the impact of feedback regulations on blood cell production and leukemia dynamics using model analysis and simulation of clinically relevant scenariosSemantic proximity
Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implicationsSemantic proximity
Mitigating non-genetic resistance to checkpoint inhibition based on multiple states of immune exhaustionSemantic proximity
Data and implication based comparison of two chronic myeloid leukemia models.Semantic proximity
The ecology in the hematopoietic stem cell niche determines the clinical outcome in chronic myeloid leukemiaSemantic proximity
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuationSemantic proximity
Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvementSemantic proximity
Select a neighboring publication to make it the new centre.